News
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company ...
Detailed price information for Pharmather Hldgs Ltd (PHRM-CN) from The Globe and Mail including charting and trades.
GlobalData on MSN3d
Third time lucky as PharmaTher gets FDA approval for ketamine
Canada-based PharmaTher has received US Food and Drug Administration (FDA) approval for its ketamine therapy for surgical ...
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the ...
The latest announcement is out from PharmaTher Holdings Ltd ( ($TSE:PHRM) ). PharmaTher Holdings Ltd. has received FDA approval for its ketamine ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the ...
The psychedelic pharmaceutical sector continues gaining mainstream acceptance as regulatory barriers fall and medical ...
The FDA has approved Ketarx, a ketamine-based drug developed by drugmaker PharmaTher, for use in pain management. The medication is now cleared by the FDA for clinical use in perioperative settings, ...
TipRanks on MSN4d
PharmaTher’s KETARx™ Gains FDA Approval, Paving Way for Expansion
PharmaTher Holdings Ltd ( ($TSE:PHRM) ) just unveiled an update. PharmaTher Holdings Ltd. has received FDA approval for its ketamine product, ...
The Parkinson’s disease (PD) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, the UK and Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback